IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer

Published:2024-02 Issue:2 Volume:27 Page:108984
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Leslie Amy R.,Ning Shu,Armstrong Cameron M.,D’Abronzo Leandro S.,Sharifi Masuda,Schaaf Zachary A.,Lou Wei,Liu Chengfei,Evans Christopher P.,Lombard Alan P.,Gao Allen C.

Funder

NCI

US Department of Veterans Affairs

DOD

Publisher

Elsevier BV

Reference67 articles.

1. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012;Ferlay;Eur. J. Cancer,2013

2. Androgen receptor in prostate cancer;Heinlein;Endocr. Rev.,2004

3. Role of Androgen Receptor in Prostate Cancer: A Review;Fujita;World J. Mens Health,2019

4. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion. Nature clinical practice;Harris;Urology,2009

5. Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression;Shafi;Steroids,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3/AKT pathway and synergizes with PARP inhibitor;Biomedicine & Pharmacotherapy;2024-10

2. Identification of vitamin D-related signature for predicting the clinical outcome and immunotherapy response in hepatocellular carcinoma;Medicine;2024-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP